MAP2K1 and cystic fibrosis: The results from this study demonstrate that inhibition of the MEK1/2 pathway decreases LPS-induced production of IL-1β and secretion of IL-8 by CF macrophages, two key inflammatory mediators that potentiate TLR4-mediated recruitment of neutrophils and tissue damage.